Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip A Gurnev

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
European Biophysics Journal : EBJ|February 14, 2006
Actin and amphiphilic polymers influence on channel formation by Syringomycin E in lipid bilayersAndrey N Bessonov, Ludmila V Schagina, Jon Y Takemoto, et al.
Cellular and Molecular Life Sciences : CMLS|November 25, 2019
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
The Journal of Biological Chemistry|September 4, 2015
Evidence of Distinct Channel Conformations and Substrate Binding Affinities for the Mitochondrial Outer Membrane Protein Translocase Pore Tom40Adam J Kuszak, Daniel Jacobs, Philip A Gurnev, et al.
Biophysical Journal|February 11, 2014
Alpha-synuclein lipid-dependent membrane binding and translocation through the α-hemolysin channelPhilip A Gurnev, Thai Leong Yap, Candace M Pfefferkorn, et al.
The Journal of Biological Chemistry|June 10, 2015
α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson DiseaseTatiana K Rostovtseva, Philip A Gurnev, Olga Protchenko, et al.
Cellular and Molecular Life Sciences : CMLS|June 19, 2022
Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatmentMegha Rajendran, María Queralt-Martín, Philip A Gurnev, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Biophysics Journal : EBJ|February 14, 2006
Actin and amphiphilic polymers influence on channel formation by Syringomycin E in lipid bilayersAndrey N Bessonov, Ludmila V Schagina, Jon Y Takemoto, et al.
Cellular and Molecular Life Sciences : CMLS|November 25, 2019
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
The Journal of Biological Chemistry|September 4, 2015
Evidence of Distinct Channel Conformations and Substrate Binding Affinities for the Mitochondrial Outer Membrane Protein Translocase Pore Tom40Adam J Kuszak, Daniel Jacobs, Philip A Gurnev, et al.
Biophysical Journal|February 11, 2014
Alpha-synuclein lipid-dependent membrane binding and translocation through the α-hemolysin channelPhilip A Gurnev, Thai Leong Yap, Candace M Pfefferkorn, et al.
The Journal of Biological Chemistry|June 10, 2015
α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson DiseaseTatiana K Rostovtseva, Philip A Gurnev, Olga Protchenko, et al.
Cellular and Molecular Life Sciences : CMLS|June 19, 2022
Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatmentMegha Rajendran, María Queralt-Martín, Philip A Gurnev, et al.
Pageof 4